Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1216 of 5804
-
Targeted radiation drug takes aim at bone metastases in early trial
Disease control Recruiting nowA multicenter, open-label Phase I clinical trial to evaluate the safety, tolerability, pharmacokinetics, dosimetry and efficacy of SKB107 in subjects with advanced solid tumors with bone metastases.
Phase: PHASE1 • Sponsor: Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC
-
New hope for kids with rare brain tumors: experimental drug enters human testing
Disease control Recruiting nowThis is a phase I, open-label, dose-escalation and expansion study to evaluate the safety, tolerability, PK of HSK42360 when given orally in pediatric patients with active BRAF V600 mutation recurrent malignant brain tumors.
Phase: PHASE1 • Sponsor: Haisco Pharmaceutical Group Co., Ltd. • Aim: Disease control
Last updated Jun 26, 2026 15:15 UTC
-
Virtual reality boosts arm recovery in stroke patients
Symptom relief Recruiting nowStroke ranks second among the leading causes of death worldwide and third among the causes of disability. In stroke patients, motor impairment typically affects facial movements and the upper and lower extremities unilaterally. Upper extremity involvement, in particular, negative…
Phase: NA • Sponsor: Istanbul Physical Medicine Rehabilitation Training and Research Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 09:00 UTC
-
Immunotherapy drug cemiplimab takes on rare, incurable cancer
Disease control Recruiting nowThis phase II trial studies how well cemiplimab works in treating patients with nuclear protein of testis (NUT) carcinoma for which no treatment is currently available (incurable) and that has spread from where it first started (primary site) to other places in the body (metastat…
Phase: PHASE2 • Sponsor: Northwestern University • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
New pill could melt fat in people with obesity
Disease control OngoingThis is a randomized, double-blind, placebo-controlled study evaluating the effects of aleniglipron on body composition in participants living with obesity. Participants will be randomized to aleniglipron or placebo in a ratio of 5:1. Participants will receive multiple ascending …
Phase: PHASE2 • Sponsor: Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
Could custom doses of prostate cancer radiation be safer and stronger?
Disease control Recruiting nowThe goal of this clinical trial is to assess if a personalized regime of 177Lu-PSMA-617 (Lutetium Lu 177 vipivotide tetraxetan, also known as Pluvicto) is feasible and safe in a population of patients with metastatic castrate-resistant prostate cancer (mCRPC). The main questions …
Phase: PHASE1 • Sponsor: Jean-Mathieu Beauregard • Aim: Disease control
Last updated Jun 26, 2026 14:37 UTC
-
New PET scan tracer could sharpen view of melanoma treatment response
Diagnosis Recruiting nowThe goal of this clinical trial is to investigate the use of the tracer \[68Ga\]Ga-FAPI-46 for PET/CT-imaging in response evaluation of patients with advanced stage malignant melanoma treated with immune checkpoint inhibitor therapy (ICT). The main question it aims to answer is: …
Phase: PHASE2 • Sponsor: Barbara Malene Fischer • Aim: Diagnosis
Last updated Jun 27, 2026 07:54 UTC
-
Pre-surgery boot camp may boost recovery for frail cancer patients
Disease control Recruiting nowIn this 2-arm, non-randomized, phase II trial, the investigators will evaluate the efficacy and safety of comprehensive multimodal prehabilitation (CMMP) alone or in combination with planned neoadjuvant (NAT) in pre-frail/frail patients with probable/proven pancreaticobiliary, ov…
Phase: PHASE2 • Sponsor: The Methodist Hospital Research Institute • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC
-
New study offers free STI care to black youth in the deep south
Disease control Recruiting nowThis study includes testing for four STIs (chlamydia, gonorrhea, syphilis, and HIV) at no cost. If positive, individual subjects will also be counseled and offered options for treatment for themselves and their sex partners that may include no cost expedited treatment and the opt…
Phase: NA • Sponsor: Tulane University • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
New hope for amputees: nerve surgery may ease phantom limb pain
Symptom relief Recruiting nowRationale: Postamputation pain (PAP) is frequently seen after amputations and is a severe lifelong disabling condition affecting quality of life (QoL). Different nerve surgical techniques are available to treat PAP if non-surgical treatment options are not sufficient. Multiple te…
Sponsor: Leiden University Medical Center • Aim: Symptom relief
Last updated Jun 27, 2026 12:37 UTC
-
New hope for early Alzheimer's? drug GSK4527226 tested for Long-Term safety
Disease control Recruiting nowThe study medicine GSK4527226 is being studied in participants with Alzheimer's Disease (AD) in study 219867 (the parent study, NCT06079190). This new study is an extension of that parent study called an open-label extension (OLE). An OLE is a clinical trial where all participant…
Phase: PHASE2 • Sponsor: GlaxoSmithKline • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
New antibody drug shows promise for tough ulcerative colitis cases
Disease control Recruiting nowThe aim of the study is to evaluate the efficacy, safety, pharmacokinetics, pharmacodynamics and immunogenicity of study drug (BCD-261) in comparison with placebo and to characterize the dose-response relationship in patients with moderate to severe active ulcerative colitis. The…
Phase: PHASE2 • Sponsor: Biocad • Aim: Disease control
Last updated Jun 26, 2026 18:48 UTC
-
New hope for Crohn's? experimental antibody BCD-261 enters Mid-Stage trial
Disease control Recruiting nowThe aim of the study is to evaluate the efficacy, safety, pharmacokinetics, pharmacodynamics and immunogenicity of study drug (BCD-261) in comparison with placebo and to characterize the dose-response relationship in patients with moderate to severe active Crohn's Disease. The st…
Phase: PHASE2 • Sponsor: Biocad • Aim: Disease control
Last updated Jun 26, 2026 18:16 UTC
-
New epilepsy drug shows promise in Long-Term safety trial
Disease control Recruiting nowCB03-154 is an investigational drug developed by Shanghai Zhimeng Biopharma Inc. for the treatment of Focal Epilepsy.
Phase: PHASE2 • Sponsor: Shanghai Zhimeng Biopharma, Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
Phone-based program aims to get seniors moving and reduce arthritis pain
Symptom relief Recruiting nowThe experience of chronic pain powerfully and negatively affects quality of life and functional independence in aging. Unfortunately, while as many as three in four older adults experience chronic pain, few have access to effective non-pharmacological pain management strategies. …
Phase: PHASE2 • Sponsor: Wake Forest University • Aim: Symptom relief
Last updated Jun 27, 2026 09:07 UTC
-
Could virtual reality help kids with brain disorders learn and move better?
Symptom relief Recruiting nowNeurodevelopmental disorders, such as Cerebral Palsy (CP), Attention-Deficit/Hyperactivity Disorder (ADHD), Autism Spectrum Disorder (ASD), are complex conditions that affect various aspects of children's development. Despite advancements in treatments, conventional rehabilitativ…
Phase: NA • Sponsor: IRCCS Centro Neurolesi Bonino Pulejo • Aim: Symptom relief
Last updated Jun 27, 2026 09:08 UTC
-
New study tests Volunteer-Based smoking cessation for stressed SGM communities
Disease control Recruiting nowSexual and/or gender minority (SGM) people face a disproportionate burden of cancer risk, and tobacco use is a key modifiable risk factor. SGM tobacco-related disparities are especially pronounced in places with high levels of stigma against SGM people. This community-engaged and…
Phase: PHASE2, PHASE3 • Sponsor: University of Oklahoma • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
Radiation boost may help control advanced pancreatic cancer
Disease control Recruiting nowThis is a Phase II, multicenter, randomized controlled trial to assess the efficacy of Stereotactic Body Radiotherapy (SBRT) in combination with maintenance therapy in patients with advanced pancreatic cancer. The aim is to compare the efficacy of SBRT combined with maintenance t…
Phase: PHASE2 • Sponsor: Shandong Cancer Hospital and Institute • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
Neck fracture showdown: surgery or brace for seniors?
Disease control Recruiting nowThe goal of this clinical trial is to compare two treatment options-surgery or rigid collar bracing-for unstable neck fractures (odontoid fractures) in adults aged 70 years and older. These fractures are common in older adults and can significantly impact mobility, independence, …
Phase: NA • Sponsor: Technical University of Munich • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
Experimental cocktail aims to outsmart Hard-to-Treat breast cancer
Disease control Recruiting nowThe goal of this clinical research study is to find the best dose of the drugs cyclophosphamide and axatilimab that can be given in combination with the standard dose of retifanlimab to patients with metastatic TNBC.
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC